166 related articles for article (PubMed ID: 9712461)
1. Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
Linssen-Schuurmans CD; van Kan EJ; Feith GW; Uges DR
Ther Drug Monit; 1998 Aug; 20(4):385-6. PubMed ID: 9712461
[TBL] [Abstract][Full Text] [Related]
2. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
Chaudhari D; Ginn D
Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient.
Strumia S; De Mitri P; Bionda E
Eur J Neurol; 2004 Jan; 11(1):68-9. PubMed ID: 14692893
[No Abstract] [Full Text] [Related]
4. Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.
Pipili C; Pantelias K; Deda E; Tsiamalos P; Kostis E; Grapsa E
Ren Fail; 2013; 35(2):289-90. PubMed ID: 23176110
[TBL] [Abstract][Full Text] [Related]
5. Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
Kambhampati G; Pakkivenkata U; Kazory A
Eur J Neurol; 2011 Mar; 18(3):e33. PubMed ID: 21087359
[No Abstract] [Full Text] [Related]
6. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Iwasawa H; Nanri K; Yamazaki T
Clin Nephrol; 2002 Aug; 58(2):168-70. PubMed ID: 12227692
[No Abstract] [Full Text] [Related]
7. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
Smiley ML; Murray A; de Miranda P
Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
[No Abstract] [Full Text] [Related]
8. The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.
Le Meur Y; Mons S; Moesch C; Leroux-Robert C
Nephrol Dial Transplant; 2000 Mar; 15(3):442. PubMed ID: 10692544
[No Abstract] [Full Text] [Related]
9. Aseptic meningitis related to valacyclovir.
Fobelo MJ; Corzo Delgado JE; Romero Alonso A; Gómez-Bellver MJ
Ann Pharmacother; 2001 Jan; 35(1):128-9. PubMed ID: 11197578
[No Abstract] [Full Text] [Related]
10. [Neurotoxicity of valacyclovir in a peritoneal dialysis patient].
Takayanagi A; Maehana T; Kyoda Y; Yanase M
Hinyokika Kiyo; 2010 Nov; 56(11):617-9. PubMed ID: 21187705
[TBL] [Abstract][Full Text] [Related]
11. Vasculitic mononeuritis multiplex induced by valacyclovir.
Pary LF; Henszel A; Kelkar P
Neurology; 2004 May; 62(10):1906-7. PubMed ID: 15159513
[No Abstract] [Full Text] [Related]
12. Beyond efficacy: new issues for HSV antiviral therapy.
Wald A
Genitourin Med; 1997 Apr; 73(2):83-4. PubMed ID: 9215085
[No Abstract] [Full Text] [Related]
13. Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy.
Lammintausta K; Mäkelä L; Kalimo K
Contact Dermatitis; 2001 Sep; 45(3):181. PubMed ID: 11553156
[No Abstract] [Full Text] [Related]
14. Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
Prasad B; McIsaac M; Toppings J
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28765478
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
[TBL] [Abstract][Full Text] [Related]
16. Pediatric uses of valacyclovir, penciclovir and famciclovir.
Dekker CL; Prober CG
Pediatr Infect Dis J; 2001 Nov; 20(11):1079-81. PubMed ID: 11734715
[No Abstract] [Full Text] [Related]
17. Valacyclovir neurotoxicity: clinical experience and review of the literature.
Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H
Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258
[TBL] [Abstract][Full Text] [Related]
18. [Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case].
Sagawa N; Tsurutani Y; Nomura K; Okuyama T; Kondo M; Sata A; Miyao M; Mizuno Y
Nihon Ronen Igakkai Zasshi; 2014; 51(6):581-5. PubMed ID: 25749332
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
20. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
